Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data
Open Access
- 25 November 2023
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 23 (1) , 1-11
Abstract
Background: Most existing predictive models of hepatocellular carcinoma (HCC) risk after sustained virologic response (SVR) are built on data collected at baseline and therefore have limited accuracy. The current study aimed to construct an accurate predictive model incorporating longitudinal data using a novel modeling strategy. The predictive performance of the longitudinal model was also compared with a baseline model. Methods: A total of 400 patients with HCV-related cirrhosis who achieved SVR with direct-acting antivirals (DAA) were enrolled in the study. Patients were randomly divided into a training set (70%) and a validation set (30%). Informative features were extracted from the longitudinal variables and then put into the random survival forest (RSF) to develop the longitudinal model. A baseline model including the same variables was built for comparison. Results: During a median follow-up time of approximately 5 years, 25 patients (8.9%) in the training set and 11 patients (9.2%) in the validation set developed HCC. The areas under the receiver-operating characteristics curves (AUROC) for the longitudinal model were 0.9507 (0.8838–0.9997), 0.8767 (0.6972,0.9918), and 0.8307 (0.6941,0.9993) for 1-, 2- and 3-year risk prediction, respectively. The brier scores of the longitudinal model were also relatively low for the 1-, 2- and 3-year risk prediction (0.0283, 0.0561, and 0.0501, respectively). In contrast, the baseline model only achieved mediocre AUROCs of around 0.6 (0.6113, 0.6213, and 0.6480, respectively). Conclusions: Our longitudinal model yielded accurate predictions of HCC risk in patients with HCV-relate cirrhosis, outperforming the baseline model. Our model can provide patients with valuable prognosis information and guide the intensity of surveillance in clinical practice.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (82273691)
- Natural Science Foundation of Jiangsu Province (BK20190106)
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
- Nanjing Important Science & Technology Specific Projects (2021-11005)
- National Natural Youth Science Foundation of China (81703273)
This publication has 39 references indexed in Scilit:
- Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated AnalysisGastroenterology, 2017
- Fast covariance estimation for sparse functional dataStatistics and Computing, 2017
- Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradicationJournal of Hepatology, 2017
- Dynamic prediction of risk of liver‐related outcomes in chronic hepatitis C using routinely collected dataJournal of Viral Hepatitis, 2016
- Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into PracticeClinical Gastroenterology and Hepatology, 2015
- Improvement of predictive models of risk of disease progression in chronic hepatitis C by incorporating longitudinal dataHepatology, 2015
- Quantifying and Comparing Dynamic Predictive Accuracy of Joint Models for Longitudinal Marker and Time-to-Event in Presence of Censoring and Competing RisksBiometrics, 2014
- Evaluating Random Forests for Survival Analysis Using Prediction Error Curves2012
- Measures of Diagnostic Accuracy: Basic Definitions2009
- Random survival forestsThe Annals of Applied Statistics, 2008